Potentially, new tumor biomarkers could be used to build up efficient new blood checks for monitoring cancer, comparable to blood glucose lab tests used to monitor diabetes, or the high sensitivity C-reactive protein check for heart disease, Dr. Hoon described. His department is regarded internationally for discovering genetic and epigenetic biomarkers for many types of solid tumor cancers. The Abraxis grant addresses several novel techniques for identifying new tumor biomarkers. In the initial phase, investigators shall search for protein biomarkers in prostate and breasts cancer tissues.Buxbaum, PhD, Director of the Seaver Autism Middle at the Icahn School of Medicine at Mount Sinai, along with professionals in genetics, statistical genetics, epidemiology, and ASD clinicians. The panel will develop a study process that will permit the question of the female protective effect to be correctly addressed. The other advisory panel associates are: Somer Bishop, PhD ; Ed Cook, MD ; Tag Daly, PhD ; Bernie Devlin, PhD ; Elise Robinson, PhD ; Kathryn Roeder, PhD ; Stephan Sanders, PhD ; Celine Saulnier, PhD ; Paige Siper, PhD ; Huda Zoghbi, PhD ; and Lonnie Zwaigenbaum, MD . ‘The female protective effect is a very important area of investigation in the autism study community and the Autism Sisters Project is going to jumpstart the procedure of developing a necessary cohort of unaffected woman siblings,’ said Dr.